Search results
Showing 76 to 90 of 207 results for arthritis
for head-to-head comparisons between biological treatments for psoriatic arthritis, particularly in people for whom treatment with...
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis
This indicator covers the percentage of patients with moderate or severe frailty and/or multimorbidity who have received a medication review in the last 12 months which is structured, has considered the use of a recognised tool and taken place as a shared discussion. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM186
remission, response, low or high disease activity or flares in rheumatoid arthritis Any explanatory notes(if applicable) Source guidance...
Evidence-based recommendations on mini-incision surgery for total knee replacement. This involves using specially designed instruments to replace the knee using a smaller incision.
View recommendations for IPG345Show all sections
Sections for IPG345
Osteoarthritis in over 16s: diagnosis and management (NG226)
This guideline covers the diagnosis, assessment and non-surgical management of osteoarthritis. It aims to improve management of osteoarthritis and the quality of life for people with osteoarthritis.
Evidence-based recommendations on total wrist replacement. This involves creating an artificial wrist joint consisting of metal implants attached to the end of the arm and to the hand, separated by a spacer to allow movement.
View recommendations for IPG271Show all sections
Sections for IPG271
Older people with social care needs and multiple long-term conditions (NG22)
This guideline covers planning and delivering social care and support for older people who have multiple long-term conditions. It promotes an integrated and person-centred approach to delivering effective health and social care services.
Summary of the evidence on infliximab for treating refractory extrapulmonary sarcoidosis to inform local NHS planning and decision-making
In development [GID-TA11352] Expected publication date: TBC
Evidence on the safety and efficacy of lateral elbow resurfacing for arthritis is limited in quantity and quality. Therefore, this...
This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable injury or disease.
David Chandler David is chief executive of the Psoriasis and Psoriatic Arthritis Alliance (PAPAA), a UK patient charity, and an...
activity, severity and impact for people with both psoriasis and psoriatic arthritis? Any explanatory notes(if applicable) Why this is...
Awaiting development [GID-TA11328] Expected publication date: TBC